Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
ACS Nano|June 19, 2024
Nanozymes: Potential Therapies for Reactive Oxygen Species Overproduction and Inflammation in Ischemic Stroke and Traumatic Brain InjuryYunfan Yang, Zixiang Li, Xiaochong Fan, et al.The Journal of Physical Chemistry. B|August 20, 2025
A Theoretical Study on Tailoring the Nitrile Substitution Strategy in Carbonates for Lithium-Ion BatteriesHaoxuan He, Jiawei Chen, Xinyu Li, et al.Signal Transduction and Targeted Therapy|May 14, 2024
2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasisFu Peng, Minru Liao, Wenke Jin, et al.Journal of Medicinal Chemistry|August 13, 2021
Discovery of an M-Substituted N-Cyclopropylmethyl-7α-phenyl-6,14-endoethanotetrahydronorthebaine as a Selective, Potent, and Orally Active κ-Opioid Receptor Agonist with an Improved Central Nervous System Safety ProfileQian He, Yuanyuan Wei, Xiao Liu, et al.Zhonghua Yi Xue Za Zhi|May 25, 2017
[Evaluation of CT-guided iodine-125 seeds brachytherapy for intracranial malignant tumors under control of target and dose]X K Hu, L J Peng, S F Liu, et al.Small (Weinheim an Der Bergstrasse, Germany)|April 17, 2023
Boosting Glioblastoma Therapy with Targeted Pyroptosis InductionXinggang Fang, Zhuo Chen, Wenhui Zhou, et al.Journal of Medicinal Chemistry|July 28, 2022
SLL-627 Is a Highly Selective and Potent κ Opioid Receptor (KOR) Agonist with an Unexpected Nonreduction in Locomotor ActivityLinghui Kong, Xuelian Shu, Siyuan Tang, et al.ACS Chemical Neuroscience|March 2, 2021
Exploration of the SAR Connection between Morphinan- and Arylacetamide-Based κ Opioid Receptor (κOR) Agonists Using the Strategy of BridgingXiao Liu, Shuang Jiang, Linghui Kong, et al.Bioorganic & Medicinal Chemistry|September 4, 2025
Design, synthesis, and biological activity of novel para-substituted phenylamino and phenyl derivatives of northebaine as selective delta opioid receptor agonistsDenggao Zhang, Jiangwen Gui, Linghui Kong, et al.European Journal of Medicinal Chemistry|July 6, 2023
Reversal of subtype-selectivity and function by the introduction of a para-benzamidyl substituent to N-cyclopropylmethyl nornepenthoneLinghui Kong, Kuan Ning, Xiao Liu, et al.Pageof 9